• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[DNAX辅助分子-1通过白细胞介素-2/信号转导和转录激活因子5途径调节1型调节性T细胞的增殖和功能]

[DNAM-1 regulates the proliferation and function of T regulatory type 1 cells the IL-2/STAT5 pathway].

作者信息

Wang N, Wang Y, Jiang P, Lü M, Hu Z, Xu X

机构信息

Institute of Basic Medicine, Xi'an Medical University, Xi'an 710021, China.

Department of General Practitioners, Xi'an Medical University, Xi'an 710021, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2022 Sep 20;42(9):1288-1295. doi: 10.12122/j.issn.1673-4254.2022.09.03.

DOI:10.12122/j.issn.1673-4254.2022.09.03
PMID:36210700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9550559/
Abstract

OBJECTIVE

To explore the role of DNAM-1 in the activation, proliferation and function of type Ⅰ regulatory T cells (Tr1 cells).

METHODS

Anti-CD3/CD28 antibodies were used to stimulate mouse T cells derived from the spleen of wild-type (WT) mice, and the expression level of DNAM-1 in resting and activated Tr1 cells was evaluated with flow cytometry. Na?ve CD4 T cells isolated by magnetic cell sorting from the spleens of WT mice and DNAM-1 knockout (KO) mice were cultured in Tr1 polarizing conditions for 3 days, after which CD25 and CD69 expressions were measured using flow cytometry. The induced Tr1 cells were labelled with CFSE and cultured in the presence of anti-CD/CD28 antibodies for 3 days, and their proliferative activity was analyzed. The expressions of IL-10 and p-STAT5 in DNAM-1-deficient Tr1 cells were detected before and after IL-2 stimulation.

RESULTS

The expression level of DNAM-1 was significantly upregulated in CD4 T cells and Tr1 cells after stimulation with anti-CD3/CD28 antibodies ( < 0.05). DNAM-1 knockout did not cause significant changes in the number or proportion of Tr1 cells, but but significantly increased the expression levels of the activation markers CD69 and CD25 ( < 0.05). Compared with WT Tr1 cells, DNAM-1-deficient Tr1 cells exhibited reduced proliferative activity ( < 0.05) with downregulated IL-10 production ( < 0.05) and decreased expressions of Il-10 and Gzmb mRNA ( < 0.05). In DNAM-1-deficient Tr1 cells, IL-2 stimulation significantly reduced IL-10 secretion level and the expression of p-STAT5 as compared with WT Tr1 cells.

CONCLUSION

DNAM-1 participate in the activation and proliferation of Tr1 cells and affect the biological functions of Tr1 cells through the IL-2/STAT5 pathway.

摘要

目的

探讨DNAX辅助分子-1(DNAM-1)在Ⅰ型调节性T细胞(Tr1细胞)激活、增殖及功能中的作用。

方法

用抗CD3/CD28抗体刺激野生型(WT)小鼠脾脏来源的小鼠T细胞,采用流式细胞术评估静息和激活的Tr1细胞中DNAM-1的表达水平。通过磁珠细胞分选从WT小鼠和DNAM-1基因敲除(KO)小鼠脾脏中分离出的初始CD4 T细胞,在Tr1极化条件下培养3天,之后用流式细胞术检测CD25和CD69的表达。将诱导的Tr1细胞用羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)标记,并在抗CD3/CD28抗体存在的情况下培养3天,分析其增殖活性。在白细胞介素-2(IL-2)刺激前后,检测DNAM-1缺陷型Tr1细胞中白细胞介素-10(IL-10)和磷酸化信号转导子和转录激活子5(p-STAT5)的表达。

结果

用抗CD3/CD28抗体刺激后,CD4 T细胞和Tr1细胞中DNAM-1的表达水平显著上调(P<0.05)。DNAM-1基因敲除未引起Tr1细胞数量或比例的显著变化,但显著增加了激活标志物CD69和CD25的表达水平(P<0.05)。与WT Tr1细胞相比,DNAM-1缺陷型Tr1细胞的增殖活性降低(P<0.05),IL-10产生下调(P<0.05),Il-10和颗粒酶B(Gzmb)mRNA的表达降低(P<0.05)。在DNAM-1缺陷型Tr1细胞中,与WT Tr1细胞相比,IL-2刺激显著降低了IL-10分泌水平和p-STAT5的表达。

结论

DNAM-1参与Tr1细胞的激活和增殖,并通过IL-2/STAT5途径影响Tr1细胞的生物学功能。

相似文献

1
[DNAM-1 regulates the proliferation and function of T regulatory type 1 cells the IL-2/STAT5 pathway].[DNAX辅助分子-1通过白细胞介素-2/信号转导和转录激活因子5途径调节1型调节性T细胞的增殖和功能]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Sep 20;42(9):1288-1295. doi: 10.12122/j.issn.1673-4254.2022.09.03.
2
CD226 deficiency attenuates the homeostasis and suppressive capacity of Tr1 cells.CD226 缺乏会减弱 Tr1 细胞的稳态和抑制能力。
Mol Immunol. 2021 Apr;132:192-198. doi: 10.1016/j.molimm.2021.01.002. Epub 2021 Jan 13.
3
CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype.CD55 共刺激诱导具有稳定表型的离散 T 调节性 1 细胞群的分化。
J Immunol. 2013 Dec 15;191(12):5895-903. doi: 10.4049/jimmunol.1301458. Epub 2013 Nov 6.
4
The role of STAT3 and AhR in the differentiation of CD4+ T cells into Th17 and Treg cells.信号转导和转录激活因子3(STAT3)及芳烃受体(AhR)在CD4+ T细胞分化为辅助性T细胞17(Th17)和调节性T细胞(Treg)过程中的作用。
Medicine (Baltimore). 2017 Apr;96(17):e6615. doi: 10.1097/MD.0000000000006615.
5
CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.CD4+ Th2 细胞通过删除单个细胞因子 IL-6 和 IL-10 基因,与效应性 Tr1 和 Th1 细胞发挥相似功能。
Mol Immunol. 2012 Jun;51(2):143-9. doi: 10.1016/j.molimm.2012.02.120. Epub 2012 Mar 17.
6
Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.抑制和肠道修复功能的人类 1 型 T 调节细胞。
Gastroenterology. 2019 Dec;157(6):1584-1598. doi: 10.1053/j.gastro.2019.09.002. Epub 2019 Sep 10.
7
Suppression of allogeneic T cells proliferation by CD3/CD46-induced T-regulatory 1 cells.CD3/CD46诱导的调节性T1细胞对同种异体T细胞增殖的抑制作用。
J Huazhong Univ Sci Technolog Med Sci. 2010 Jun;30(3):332-6. doi: 10.1007/s11596-010-0352-5. Epub 2010 Jun 17.
8
IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.IL-2 激活 STAT5 可增强人细胞毒性调节性 T 细胞 HOZOT 产生 IL-10 的能力。
Exp Hematol. 2008 Feb;36(2):181-92. doi: 10.1016/j.exphem.2007.09.010. Epub 2007 Nov 26.
9
CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.CD69 与 Jak3/Stat5 蛋白的关联调节 Th17 细胞分化。
Mol Cell Biol. 2010 Oct;30(20):4877-89. doi: 10.1128/MCB.00456-10. Epub 2010 Aug 9.
10
IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.干扰素-α和白细胞介素-10诱导人1型调节性T细胞分化。
J Immunol. 2001 May 1;166(9):5530-9. doi: 10.4049/jimmunol.166.9.5530.

引用本文的文献

1
[High expression of COX6B2 in gastric cancer is associated with poor long-term prognosis and promotes cell proliferation and cell cycle progression by inhibiting p53 signaling].[COX6B2在胃癌中的高表达与长期预后不良相关,并通过抑制p53信号促进细胞增殖和细胞周期进程]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Feb 20;44(2):289-297. doi: 10.12122/j.issn.1673-4254.2024.02.11.

本文引用的文献

1
DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.DNAM-1 通过在炎症条件下干扰 TIGIT 来调节调节性 T 细胞中 Foxp3 的表达。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2021309118.
2
Suppression of Th1 and Th17 Proinflammatory Cytokines and Upregulation of FOXP3 Expression by a Humanized Anti-DNAM-1 Monoclonal Antibody.一种人源化抗 DNAM-1 单克隆抗体对 Th1 和 Th17 促炎细胞因子的抑制作用及 FOXP3 表达的上调。
Monoclon Antib Immunodiagn Immunother. 2021 Apr;40(2):52-59. doi: 10.1089/mab.2020.0042.
3
CD226 deficiency attenuates the homeostasis and suppressive capacity of Tr1 cells.CD226 缺乏会减弱 Tr1 细胞的稳态和抑制能力。
Mol Immunol. 2021 Apr;132:192-198. doi: 10.1016/j.molimm.2021.01.002. Epub 2021 Jan 13.
4
CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model.CD226 通过 Akt 和 Erk 信号通路在 EAE 模型中抑制调节性 T 细胞增殖。
Front Immunol. 2020 Aug 21;11:1883. doi: 10.3389/fimmu.2020.01883. eCollection 2020.
5
CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.CD226 通过 CTLA-4 和 TIGIT 在 EAE 中减弱 Treg 的抑制能力。
Immunol Res. 2019 Dec;67(6):486-496. doi: 10.1007/s12026-019-09112-9.
6
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.DNAX辅助分子-1与TIGIT/PVRIG/TACTILE轴:基于自然杀伤细胞的癌症免疫疗法的新型免疫检查点
Cancers (Basel). 2019 Jun 23;11(6):877. doi: 10.3390/cancers11060877.
7
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?肿瘤微环境中的调节性 T 细胞(Treg 细胞):Treg 细胞能否成为新的治疗靶点?
Cancer Sci. 2019 Jul;110(7):2080-2089. doi: 10.1111/cas.14069. Epub 2019 Jun 18.
8
Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.维甲酸诱导的自身抗原特异性 1 型调节性 T 细胞抑制自身免疫。
EMBO Rep. 2019 May;20(5). doi: 10.15252/embr.201847121. Epub 2019 Mar 20.
9
The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases.调节性 T 细胞 1 型的生物学特性及其在免疫介导性疾病中的治疗应用。
Immunity. 2018 Dec 18;49(6):1004-1019. doi: 10.1016/j.immuni.2018.12.001.
10
Biology and regulation of IL-2: from molecular mechanisms to human therapy.IL-2 的生物学和调控:从分子机制到人体治疗。
Nat Rev Immunol. 2018 Oct;18(10):648-659. doi: 10.1038/s41577-018-0046-y.